PATRICIA MARTIN: Open Payments
NPI 1477223766 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 13 payments from 9 companies in 2025. Trend: 2023 $316 · 2024 $459 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Amgen Inc. | 2 | $33 |
| Novo Nordisk Inc | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: TRINTELLIX, OTEZLA, UBRELVY, QULIPTA, Ozempic, BREZTRI, Kerendia, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
